We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – Products

The Samsara therapeutics logo
Product News

Samsara Therapeutics Unveils Promising Autophagy Drug Candidate

Samsara Therapeutics has announced the company’s autophagy-inducing candidate SAM001, the first agent of its class to enter clinical trials.
Gyrolab® Generic Cyno ADA Kit Reagents
Product News

Gyros Protein Technologies Introduces Gyrolab Generic Cyno ADA Kit Reagents

Gyros Protein Technologies AB has announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
White pills on a yellow background
Product News

Pharmacogenomics Research Could Save NHS at Least £41 Million Annually

An analysis of NHS prescriptions data has revealed the huge potential for pharmacogenomics to reduce ineffective prescribing and adverse effects, which could save millions of pounds for the NHS.
One - Stop Research Support for CAR - NK Therapy content piece image
Product
Advertisement

One - Stop Research Support for CAR - NK Therapy

CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects.
The Avacta logo.
Product News

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

Avacta Group plc announces the opening of the first two clinical investigator sites for the phase 1 clinical trial of AVA6000 under its US Investigational New Drug Application.
The EpicentRx logo.
Product News

EpicentRx Receives Fast Track Designation From the U.S. FDA for Lead Asset

EpicentRx, Inc. has announced that the FDA has granted Fast Track Designation to RRx-001 for the prevention/attenuation of severe oral mucositis in chemotherapy and radiation-treated head & neck cancer patients.
Highly Sensitive Mass Spectrometry Methods for Quantifying PROTACs content piece image
App Note / Case Study

Highly Sensitive Mass Spectrometry Methods for Quantifying PROTACs

Protein-targeting chimeras (PROTACs) have gained significant attention recently due to their high potency in nanomolar drug concentrations and target selectivity. However, low test concentrations in complex matrices present analytical challenges.
The SonALAsense logo
Product News

SonALAsense Announces Completion of First Cohort in Phase 2 Study of Sonodynamic Therapy for Recurrent Glioblastoma

SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.
Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
Thermo Scientific Gallery Enzyme Master Enzyme Analyzer
Product News

Thermo Fisher Scientific’s Advanced Analytical Instruments Receive R&D 100 Awards

Thermo Fisher Scientific Inc. received R&D 100 Awards from R&D World Magazine for two of its most recently launched analytical instruments.
Advertisement